Digital Pharma's quantum leap: How AI is redefining media measuremen... Welcome to the era where the convergence of quantum computing and artificial intelligence isn't just an advantage, it's the imperative.
Sales & Marketing Optimising customer experience in global medical information... Technology and AI may come to bear in establishing global MI services.
Sales & Marketing Optimising customer experience in global medical information... In MI, it is increasingly important to find methodologies to increase global efficiencies while optimising the customer experience.
Digital Creating a winning playbook for consistent digital product s... While pharma companies are embracing the transition to digital, and investing significantly in their new products, only 4% of senior executives agree that their digital product launches are
Digital Can creative analytics solve your D2C paid search headache? Digitalisation has forever changed how we engage with healthcare.
R&D Ensuring R&D investments deliver maximum potential: Notable ... As the drug development landscape becomes more complex, pharmaceutical and biotech companies understand their business strategies have to evolve.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.